Condition: Mild Cognitive Impairment · Alzheimer Disease, Late Onset · Cognitive Impairment · Sponsor: Norwegian University of Science and Technology
The goal of this study is to learn more about the changes in the brains of patients with cognitive impairment (MCI) and Alzheimer's Disease (AD). The main questions the study aims to answer are: 1. What findings can be used to earlier detect patients that will develop Alzheimers? 2. Which differences are seen between healthy and cognitively impaired patients? 3. Which differences are seen between patients with Alzheimers disease? Participants will undergo: * Cognitive tests * Magnetic resonance imaging (MRI) * Electroencephalography (EEG) * Blood sample collection * Fecal sample collection * A randomized group will undergo polysomnography analysis.
This description comes directly from the study's public registry record.
Axel Sandvig, Prof., MD, PhD · 72 57 56 20 · axel.sandvig@ntnu.no
Always discuss trial participation with your own doctor first.
| Norwegian University of Sciene and Technology / Norges teknisk-naturvitenskapelige universitet (NTNU) | Trondheim, Trønderlag, Norway | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06448403